Oxford Biosystems & Cadama (OBC) is the exclusive UK distributor for Focus Diagnostics and for the infectious Diseases product line from IBL International. If you are looking for automation to facilitate your workload please contact us to discuss your specific requirements as we do have agreements with suppliers of automated ELISA processors.
Focus Diagnostics has played a role in the discovery and surveillance of emerging infectious diseases through the development of serological testing. Their scientists have collaborated with leading researchers and health agencies worldwide for more than three decades.
DxSelect™ serology products include a range of CE marked ELISA and IFA kits to aid in the diagnosis of emerging infectious diseases.
HerpeSelect™ type specific serology tests provide aid in the presumptive diagnosis of HSV-1 and HSV-2 in sexually active adults or expectant mothers.
For rapid molecular assays Focus Diagnostics have collaborated with 3M™ to develop the Integrated Cycler and Simplexa range of real time molecular assays and reagents.
Visit our Molecular Products page for further information or contact us directly to discuss the benefits this system can offer your laboratory.
Rapid-VIDITEST tests are simple, one step immunochromatographic assays for the qualitative detection of viral, bacterial or parasitic pathogens causing respiratory or gastrointestinal diseases.
Rapid-VIDITEST kits are CE marked and competitively priced to offer a rapid alternative to more time consuming antigen detection assays.
Kits are manufactured by Vidia spol.sro, a well established, privately owned biotech company in the Czech Republic,
Use our website search facility or contact us directly for information about these products.
IBL offers a comprehensive range of ELISA products for the detection of viral, bacterial and parasitic infections in humans.
Reagents such as wash buffers, TMB substrates and stop solutions are interchangeable between products and all products are easy to use, fully automatable and provide reliable results.
The panel of ELISAs for vaccination management is based on the detection of specific IgG and total antibodies (TAb) in serum and plasma and are calibrated against WHO standards where available. The assays are intended for use in the assessment and monitoring of immunisation status and epidemiological studies.
For specific information about individual kits please use the search facility.
Please contact us to discuss your specific requirements.